Success Story
From complexity to funding: How innoscripta simplified the Forschungszulage for T+A
Clear positioning of R&D characteristics
Targeted refinement of fundable applications
Industry
High-End Audio Equipment Manufacturing
Company Size
Medium-Sized Enterprise
Location
Herford, Germany
“innoscripta showed us that the research allowance does not have to be a bureaucratic burden. For this reason, we can recommend innoscripta without reservation.”
Meet T+A elektroakustik
T+A is a family-owned company established in 1978. The company fosters the mission of pushing the limits of what is technically possible and inventing instead of depending on existing knowledge. Headquartered in Herford, every device they make is built by a dedicated team of engineers and designers, and this approach creates products that endure for generations.
T+A’s long-term innovation includes digital signal processing, active units in loudspeakers and the world's first DSD 1024-capable player. Supported by close scientific partnerships and with the commitment to timeless design, T+A creates Hi-Fi systems that become lifelong companions, created with precision and longevity.
The Challenge
Forschungszulage was a promising funding opportunity, but accessing it involved a demanding process.
As a high-end audio equipment manufacturing company, T+A had several innovative initiatives that could potentially qualify for the research allowance. However, defining the correct plan of action to obtain funding and understanding the important elements of the programme proved to be complex. Despite their initial connections with other advisors, T+A still faced challenges in precisely developing fundable applications that highlighted the R&D qualities of the project and eligible expenses. These steps also led them to the conclusion that the research allowance process is a programme with bureaucratic hurdles.
The Solution
innoscripta delivered expert guidance that brought precision and momentum to the funding process.
innoscripta supported T+A with a results-oriented approach and helped T+A refine and articulate all the project details in their applications as specified by the concerned authorities. Additionally, innovation consulting from innoscripta enabled T+A to develop a fundable product within only a few iterations.
The Impact
The partnership transformed a burdensome process into an effective and recommendable experience. The ultimate value T+A realised is the approved funding.
innoscripta proved to T+A that obtaining financial support for qualified R&D projects through the research allowance does not have to be a bureaucratic obstacle. The combination of the streamlined process, expert guidance, and a dedicated software platform made the process remarkably easier and more productive.
